Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Textile industry to double GDP contribution by 2030: Report
- Virtual lover or digital stalker? Looking beyond the AI companionship
- KT Rama Rao, Telangana Minister and Amitabh Kant, G20 present FLO Hyderabad business awards to 20 women entrepreneurs
- CNBC-TV18 SME Champion Award for Excellence in Digital Transformation for flagship CHOICE platform
